|
|||||
|
|
Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis |
|
| Authors: | Mrinal M. Gounder MD LeAnne Maddux MA Jean Paty PhD Thomas M. Atkinson PhD |
| Affiliation: | 1. Memorial Sloan Kettering Cancer Center, New York, New York;2. IQVIA, New York, New York |
| Abstract: | |
| Keywords: | clinical outcome assessments drug development tool Food and Drug Administration (FDA) patient-reported outcome (PRO) guidance neoplasms patient-centered outcomes |